2113 studies found for:    trust-2
Show Display Options
Rank Status Study
1 Active, not recruiting Trichuris Suis Ova (TSO) Suspension Versus Placebo in Active Crohn's Disease
Condition: Crohn´s Disease
Interventions: Drug: Low dose TSO;   Drug: Medium dose TSO;   Drug: High dose TSO;   Drug: Placebo
2 Not yet recruiting ECCO2R as an Adjunct to NIV in AECOPD
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Device: NIV;   Device: ECCO2R
3 Unknown  Evaluation of the Hospital2Home Palliative Care Service for Patients With Advanced Progressive Lung Disease
Condition: Lung Disease
Intervention: Other: The Hospital2Home Service
4 Unknown  Predicting Response to Incretin Based Agents in Type 2 Diabetes
Condition: Type 2 Diabetes,
Intervention: Other: No intervention, observational study
5 Completed Regulatory T Cells in Type 1 Diabetes Patients Treated With IL-2
Condition: Type 1 Diabetes
Intervention: Drug: Aldesleukin (Proleukin)
6 Not yet recruiting The Cost in Oxygen of Surgical Trauma
Conditions: Oxygen Consumption (V̇O2);   Oxygen Delivery (DO2);   Post-operative Complications
Intervention:
7 Recruiting Effect of Testosterone on Endothelial Function and Microcirculation in Type 2 Diabetic Patients With Hypogonadism
Conditions: Type 2 Diabetes;   Hypogonadism
Intervention: Drug: Testosterone
8 Recruiting Gene Therapy for Blindness Caused by Choroideremia
Condition: Choroideremia
Intervention: Drug: rAAV2.REP1
9 Recruiting Progression of Coronary Atherosclerosis in Asymptomatic Diabetic Subjects
Conditions: Type 2 Diabetes;   Coronary Artery Disease
Intervention:
10 Enrolling by invitation Is Any Additional Information Gained Regarding Margins Using 3D Tomosynthesis Vs 2D Conventional Digital Imaging When Imaging Operative Breast Specimens?
Condition: Breast Cancer
Interventions: Radiation: 3 dimensional tomosynthesis imaging;   Radiation: 2 dimensional digital imaging
11 Recruiting Proof-of-Concept Study of AZD4547 in Patients With FGFR1 or FGFR2 Amplified Tumours
Conditions: Gastric Cancer;   Oesophageal Cancer;   Breast Cancer;   Squamous Cell Carcinoma of the Lung
Intervention: Drug: AZD 4547
12 Recruiting Long Term Continuous Infusion ch14.18/CHO Plus s.c. Aldesleukin (IL-2)
Condition: Neuroblastoma
Interventions: Drug: ch14.18/CHO;   Drug: Aldesleukin;   Drug: Isotretinoin
13 Unknown  Interleukin-2 With or Without Histamine Dihydrochloride in Treating Patients With Metastatic Kidney Cancer
Condition: Kidney Cancer
Interventions: Biological: aldesleukin;   Drug: histamine dihydrochloride
14 Unknown  Detect InSpect ChAracterise Resect and Discard 2
Condition: Colonic Polyps
Intervention: Device: Narrow band imaging for 'optical diagnosis' of colonic polyps (Olympus).
15 Unknown  Lentivirus Transduced Acute Myeloid Leukaemia Blasts Expressing B7.1 (CD80) and IL-2
Condition: Leukemia, Myeloid, Acute
Interventions: Biological: RFUSIN2-AML1;   Biological: Donor leukocyte infusion (DLI);   Biological: RFUSIN2-AML1 and donor leukocyte infusion
16 Not yet recruiting TIL Therapy in Metastatic Melanoma and IL2 Dose Assessment
Condition: Metastatic Melanoma
Interventions: Drug: Cyclophosphamide;   Drug: Fludarabine;   Genetic: Tumour Infiltrating Lymphocytes;   Drug: Interleukin-2
17 Unknown  Evaluation of Corticosteroid Therapy in Childhood Severe Sepsis - a Randomised Pilot Study
Conditions: Paediatric Sepsis;   Pediatric Sepsis
Intervention: Drug: hydrocortisone
18 Completed Assessment of Thrombogenicity in Acute Coronary Syndrome
Conditions: Type 2 Diabetes Mellitus;   Acute Coronary Syndrome
Intervention:
19 Unknown  Timed Release Tablet Prednisone in Polymyalgia Rheumatica
Condition: Polymyalgia Rheumatica
Interventions: Drug: Timed Release Tablet Prednisone;   Drug: Prednisolone
20 Suspended WT1 Immunity Via DNA Fusion Gene Vaccination in Haematological Malignancies by Intramuscular Injection Followed by Intramuscular Electroporation
Conditions: Leukaemia (Acute);   Leukaemia (Chronic);   Leukaemia (Acute Myeloid);   Leukaemia (Acute Lymphoblastic);   Leukaemia (Acute Promyelocytic)
Intervention: Biological: p.DOM-WT1-37 DNA Vaccine and p.DOM-WT1-126 DNA Vaccine

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years